Detalhe da pesquisa
1.
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
Depress Anxiety
; 27(5): 417-25, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20455246